Filter
2725
Text search:
blood
supply
Featured
Recommendations
339
New Publications
870
Language
Document type
No document type
1563
Guidelines
405
Studies & Reports
363
Manuals
163
Strategic & Response Plan
100
Training Material
55
Fact sheets
41
Situation Updates
18
Brochures
6
Infographics
5
Resource Platforms
4
App
1
Online Courses
1
Countries / Regions
India
229
Kenya
90
Sierra Leone
88
Global
87
Ethiopia
82
Liberia
71
Uganda
69
Nigeria
68
Tanzania
62
South Africa
60
Nepal
55
Ghana
51
Zambia
48
Malawi
45
Bangladesh
44
Rwanda
41
Namibia
37
Myanmar / Burma
34
Philippines
33
Western and Central Europe
28
Africa
28
Latin America and the Carribbean
27
Lesotho
25
Syria
23
Congo, Democratic Republic of
21
Zimbabwe
20
Cambodia
20
South–East Asia Region
20
Guinea
18
Asia
18
Ukraine
17
Senegal
16
Burkina Faso
13
Botswana
13
Mozambique
12
Eswatini/ Swaziland
11
East and Southern Africa
11
West and Central Africa
11
Indonesia
10
Russia
10
Cameroon
9
Afghanistan
9
Western Pacific Region
9
Eastern Europe and Central Asia
9
Eastern Europe
9
Pakistan
8
Brazil
7
Yemen
7
Venezuela
7
Georgia
6
Haiti
5
Middle East and North Africa
5
Albania
5
South Sudan
4
Laos
4
Moldova
4
United Kingdom
4
Mali
3
Côte d’Ivoire / Ivory Coast
3
Jordan
3
Thailand
3
Sudan
3
Benin
3
Colombia
3
Sri Lanka
3
Bhutan
3
Timor Leste/ East Timor
3
Tajikistan
3
Guinea-Bissau
2
USA
2
Saudi Arabia
2
Somalia
2
Iraq
2
Germany
2
Lebanon
2
Turkey
2
Chad
2
Gambia
2
China
2
Papua New Guinea
2
Central African Republic
2
Peru
2
North Macedonia
2
Bolivia
2
Chile
2
Poland
2
Kyrgyzstan
2
Vietnam
2
North America
2
Bosnia and Herzegovina
2
Morocco
1
Togo
1
Mauritania
1
Argentina
1
Serbia
1
Hungary
1
Burundi
1
Ecuador
1
Greece
1
Libya
1
Angola
1
Madagascar
1
Mexico
1
Other region
1
Paraguay
1
Fiji
1
Solomon Islands
1
Palestine
1
Armenia
1
Southern Africa
1
Estonia
1
Iran
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Spain
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1281
Clinical Guidelines
294
Women & Child Health
159
Public Health
146
Key Resources
143
Pharmacy & Technologies
61
Capacity Building
60
Annual Report MEDBOX
1
Toolboxes
HIV
202
COVID-19
158
TB
115
Caregiver
96
Ebola & Marburg
94
NTDs
80
Pharmacy
78
AMR
77
Mental Health
72
NCDs
68
Conflict
59
Planetary Health
53
Rapid Response
51
Malaria
46
Global Health Education
33
Refugee
30
Specific Hazards
25
Natural Hazards
24
2.0 Rapid Response
23
Zika
20
Cholera
19
Disability
11
Polio
10
Health Financing Toolbox
9
Social Ethics
7
Web annex 2: Carbetocin versus placebo or no treatment
Evidence to decision framework
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of maternal and child health services. As part of these efforts, the ministry is also exerting concerted efforts to improve availability and use of quality
...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
Handbook of Hospital Care for Newborn Infants
recommended
Updated June 2021
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera
...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes, the
captive audience, and the popular perception
...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co
...
Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes a framework to develop a cancer centre and/or to st
...
In line with the Climate and Environment Charter for Humanitarian Organisations which IFRC, ICRC and various Red Cross Red Crescent National Societies have endorsed, this short Guide aims to help practitioners integrate environmental and climate change considerations into their work. It has been dev
...
2nd edition
Updated Guideline.
The Emergency Triage Assessment and Treatment (ETAT) guidelines provide guidance on the most common emergency conditions in children presenting at the health facility. These include but are not limited to airway obstruction and other breathing problems; circulatory impairment or
...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
12 May 2021. This third survey in the series shows that the COVID-19 pandemic continues to impact societies, not only in terms of health, but also social and economic conditions and day-to-day life
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar
...
